Benlysta
Benlysta is a prescription medicine used to treat the symptoms of Systemic Lupus Erythematosus. Benlysta may be used alone or with other medications.
Benlysta belongs to a class of drugs called Rheumatologics.
Belimumab is a human IgG1λ monoclonal antibody specific for soluble human B lymphocyte stimulator protein (BLyS, also referred to as BAFF and TNFSF13B). Belimumab has a molecular weight of approximately 147 kDa. Belimumab is produced by recombinant DNA technology in a murine cell (NS0) expression system.
Benlysta Info
The recommended intravenous dosage regimen is 10 mg/kg at 2-week intervals for the first 3 doses and at 4-week intervals thereafter. Reconstitute, dilute, and administer as an intravenous infusion over a period of 1 hour.
Benlysta Side Effects
The most common side effects include:
- nausea,
- diarrhea,
- fever,
- sore throat,
- runny or stuffy nose,
- cough,
- pain, itching, redness, or swelling where the injection was given,
- pain in your arms or legs,
- headache,
- depressed mood, and
- sleep problems (insomnia)
Patient Assistance Programs
There are several programs patients can sign up for that will assist in treatment costs:
Resources
To learn more about this treatment, browse the resources below.
Ready to get started?
Contact us to chat with one of our helpful scheduling specialists!